| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |